Harvard Bioscience Inc.

NASDAQ: HBIO · Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM

Harvard Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.11M 4.28M 4.51M 7.82M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a -333K -1.56M
Other Long-Term Assets
2.83M 6.47M 13.6M 12.27M
Receivables
14.87M 16.1M 16.7M 21.83M
Inventory
23.25M 24.72M 26.44M 27.59M
Other Current Assets
2.9M 3.94M 3.47M 4.34M
Total Current Assets
45.12M 49.04M 51.12M 61.58M
Property-Plant & Equipment
11.24M 8.75M 3.37M 3.42M
Goodwill & Intangibles
67.46M 73.1M 77.27M 85.07M
Total Long-Term Assets
81.53M 88.33M 94.24M 100.76M
Total Assets
126.64M 137.37M 145.36M 162.34M
Account Payables
4.79M 5.55M 6.45M 4.91M
Deferred Revenue
3.81M n/a 3.37M 4.27M
Short-Term Debt
36.96M 5.86M 3.81M 3.23M
Other Current Liabilities
8.25M 13.71M 7.49M 4.71M
Total Current Liabilities
54.96M 26.54M 23.25M 25.32M
Long-Term Debt
6.38M 30.7M 43.01M 45.09M
Other Long-Term Liabilities
1.25M 1.48M 1.01M 486K
Total Long-Term Liabilities
8.35M 37.75M 49.89M 53.63M
Total Liabilities
63.3M 64.29M 73.14M 78.94M
Total Debt
44.49M 42.77M 46.82M 48.33M
Common Stock
n/a 434K 454K 452K
Retained Earnings
-158.01M -145.6M -142.19M -132.67M
Comprehensive Income
-15.67M -14.19M -15.05M -10.03M
Shareholders Equity
63.34M 73.07M 72.22M 83.4M
Total Investments
n/a n/a -333K -1.56M